Sanofi GCVRZ 深 滬
交易中 05-20 11:15:27 美东时间
0.8711
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.8711
- 總市值 1113.52亿
- 52周最高 0.882
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.43
- 委 比 0.00%
- 總股本 1278.30亿
- 歷史最高 0.882
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.153
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多赛诺菲旗下10批次吸附无细胞百白破灭活脊髓灰质炎和b型流感嗜血杆菌（结合）联合疫苗获中国药检院予以签发
5月19日消息，国家药品监督管理局旗下中国食品药品检定研究院披露的生物制品批签发产品公示情况显示，2026年5月11日至2026年5月17日，中国食品药品检定研...
05-19 20:16
FDA Drug Chief Tracey Hoeg Fired Days After After Marty Makary's Exit— Says Order Came From 'Way Above'
Tracey Beth Hoeg was fired as FDA drug division chief amid a broader Trump administration shake-up at the health department.
05-16 11:53
Regeneron Provides Update on Phase 3 Trial of Fianlimab (LAG-3 Inhibitor) Combination in First-Line Unresectable or Metastatic Melanoma
Regeneron's Phase 3 trial evaluating high-dose fianlimab combined with cemiplimab for first-line treatment of unresectable locally advanced or metastatic melanoma did not meet statistical significance for the primary endpoint of improving progression-free survival (PFS) compared to pembrolizumab monotherapy. However, a numeric improvement of 5.1 months in median PFS was observed for the high-dose combination. A Phase 3 head-to-head trial comparin...
05-16 00:19
Sanofi’s SAR445399 Lung Trial Moves Ahead: What Investors Should Watch
Sanofi SA ($SNY) announced an update on their ongoing clinical study. Sanofi (S...
05-15 00:36
BranchLab raises $26 million Series A with Sanofi Ventures participation
BranchLab raises $26 million Series A with Sanofi Ventures participation BranchLab, an AI platform focused on pharmaceutical commercialization workflows such as audience identification, activation, and measurement, raised a USD 26 million Series A led by McKesson Ventures, with participation from Sa
05-14 15:43
Transcript: Dyadic International Q1 2026 Earnings Conference Call
Dyadic International (NASDAQ:DYAI) reported first-quarter financial results on ...
05-14 05:54
药物受理最新动态：Sanofi Winthrop Industrie硫酸氢氯吡格雷片进口再注册申请获受理
国家药品监督管理局药品审评中心数据显示，2026年5月12日，Sanofi Winthrop Industrie的硫酸氢氯吡格雷片申请已获受理，受理号为JYH...
05-12 15:15
New PatentVest Pulse Report Maps the Triple-Agonist Race and the Emerging Patent Battle Shaping the Post-GLP-1 Obesity Market
PatentVest's report highlights the rapid expansion of triple-agonist programs in obesity therapeutics, with 27 global projects across major pharma companies and emerging biotechs. The study emphasizes the shift from clinical outcomes to intellectual property strategies, receptor engineering, and delivery systems as key factors shaping the next phase of competition. China is a significant player in this pipeline expansion. Companies like Eli Lilly...
05-08 14:30
Why Novavax Stock Is Trading Higher On Wednesday?
Novavax shares rise after Q1 revenue beat; partnerships, credit facility, and technical levels shape outlook amid shift to net loss.
05-07 03:07
Sanofi Supports AlphaDetect to Accelerate Detection of Alpha-1
The sponsorship helps expand proven Alpha-1 detection strategies, which will enable earlier patient identification DURHAM, N.C., May 6, 2026 /PRNewswire/ -- AlphaDetect, the nonprofit organi...
05-07 00:42
